XML 16 R48.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Stock-Based Compensation (Details 2) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 25, 2011
Jun. 26, 2010
Jun. 25, 2011
Jun. 26, 2010
Stock-based compensation weighted-average assumptions        
Expected life (in years)     4.2 4.5
Expected volatility (as a percent)     33.40% 34.00%
Risk-free interest rate (as a percent)     2.22% 2.35%
Expected dividend yield (as a percent)     0.00% 0.00%
Weighted-average grant date fair value (in dollars per share)     $ 11.35 $ 11.96
Restricted stock activity, additional disclosures        
Compensation expense $ 5,430 $ 7,712 $ 11,348 $ 14,568
Stock options.
       
Stock option activity, shares        
Options outstanding, balance at the beginning of the period (in shares)     6,594,313  
Options granted (in shares)     947,910  
Options exercised (in shares)     (591,777)  
Options canceled (in shares)     (472,605)  
Options outstanding, balance at the end of the period (in shares) 6,477,841   6,477,841  
Options exercisable, balance at the end of the period (in shares) 3,895,599   3,895,599  
Stock option activity, weighted-average exercise price        
Options outstanding, balance at the beginning of the period (in dollars per share)     $ 37.87  
Options granted (in dollars per share) $ 37.37   $ 37.37  
Options exercised (in dollars per share) $ 27.93   $ 27.93  
Options canceled (in dollars per share) $ 42.75   $ 42.75  
Options outstanding, balance at the end of the period (in dollars per share) $ 38.34   $ 38.34  
Options exercisable, balance at the end of the period (in dollars per share) $ 40.60   $ 40.60  
Stock option activity, weighted-average remaining contractual life        
Options outstanding, balance at the end of the period (in years) 4.09   4.09  
Options exercisable, balance at the end of the period (in years)     3.04  
Stock option activity, Aggregate Intrinsic Value        
Options outstanding, balance at the end of the period 27,431   27,431  
Options exercisable, balance at the end of the period 13,777   13,777  
Stock option activity, additional disclosures        
Number of unvested stock options expected to vest (in shares) 2,407,941   2,407,941  
Intrinsic value of options exercised 4,583 653 6,711 1,141
Amount of cash received from exercise of options     12,713 2,659
Actual tax benefit realized for tax deductions from option exercises     2,465 342
Charge recorded in capital in excess of par value for excess of deferred tax assets over actual tax benefits at option exercise     362  
Unrecognized compensation expense        
Unrecognized compensation cost 22,830   22,830  
Estimated weighted-average amortization period for unrecognized compensation cost (in months)     32  
Restricted stock
       
Stock option activity, additional disclosures        
Number of unvested stock options expected to vest (in shares) 672,490   672,490  
Unrecognized compensation expense        
Unrecognized compensation cost 21,783   21,783  
Estimated weighted-average amortization period for unrecognized compensation cost (in months)     31  
Restricted stock activity, restricted stock        
Balance at the beginning of the period (in shares)     777,740  
Granted (in shares)     283,450  
Vested (in shares)     (291,942)  
Canceled (in shares)     (51,159)  
Balance at the end of the period (in shares) 718,089   718,089  
Restricted stock activity, weighted average grant date fair value        
Balance at the beginning of the period (in dollars per share)     $ 35.97  
Granted (in dollars per share)     $ 37.29  
Vested (in dollars per share)     $ 37.67  
Canceled (in dollars per share) $ 38.29   $ 38.29  
Balance at the end of the period (in dollars per share) $ 35.63   $ 35.63  
Restricted stock activity, additional disclosures        
Number of unvested restricted stock expected to vest (in shares) 672,490   672,490  
Fair value of restricted stock grants that vested 861 890 10,997 9,994
Performance Based Stock Award Program
       
Restricted stock activity, additional disclosures        
Compensation expense $ 54 $ 105 $ 108 $ 286